Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yochai Adir, Omar Hakrush, Michal Shteinberg, Sonia Schneer, Alvar Agusti. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study. ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018

Member's Comments

No comment yet.

Related content which might interest you: Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Serum GAL3 predict response in omalizumab-treated patients with severe allergic asthma: the PROXIMA study Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Identifying factors associated with severe asthma exacerbations: a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 626s Year: 2007 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 A retrospective evaluation of lung function and exacerbations in COPD patients-RETRIEVE study. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016